Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proassurance (PRA) Cash & Equivalents (2016 - 2026)

Proassurance has reported Cash & Equivalents over the past 17 years, most recently at $36.5 million for Q4 2025.

  • Quarterly Cash & Equivalents fell 33.5% to $36.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $36.5 million through Dec 2025, down 33.5% year-over-year, with the annual reading at $36.5 million for FY2025, 33.5% down from the prior year.
  • Cash & Equivalents was $36.5 million for Q4 2025 at Proassurance, down from $54.5 million in the prior quarter.
  • Over five years, Cash & Equivalents peaked at $214.8 million in Q1 2021 and troughed at $30.0 million in Q4 2022.
  • The 5-year median for Cash & Equivalents is $54.7 million (2024), against an average of $75.5 million.
  • Year-over-year, Cash & Equivalents plummeted 79.61% in 2022 and then skyrocketed 119.96% in 2023.
  • A 5-year view of Cash & Equivalents shows it stood at $143.6 million in 2021, then crashed by 79.14% to $30.0 million in 2022, then skyrocketed by 119.96% to $65.9 million in 2023, then decreased by 16.72% to $54.9 million in 2024, then tumbled by 33.5% to $36.5 million in 2025.
  • Per Business Quant, the three most recent readings for PRA's Cash & Equivalents are $36.5 million (Q4 2025), $54.5 million (Q3 2025), and $41.6 million (Q2 2025).